TCVAX | VMVAX | TCVAX / VMVAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 15 years | 13 years | - |
Gain YTD | 0.715 | 1.921 | 37% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 3000 | 83% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 576M | 30.9B | 2% |
Annual Yield % from dividends | 0.84 | 2.14 | 39% |
Returns for 1 year | 2.52 | 12.44 | 20% |
Returns for 3 years | -0.46 | 15.34 | -3% |
Returns for 5 years | 17.61 | 38.46 | 46% |
Returns for 10 years | 36.55 | 81.26 | 45% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
TQMVX | 17.90 | -0.22 | -1.21% |
T. Rowe Price Integrated US LCV Eq | |||
IPLIX | 30.66 | -0.54 | -1.73% |
Voya Index Plus LargeCap Port I | |||
FSCWX | 32.97 | -0.65 | -1.93% |
Nuveen Small Cap Value R6 | |||
NGDLX | 29.73 | -0.59 | -1.95% |
Neuberger Berman Large Cap Growth Inst | |||
JGVVX | 43.04 | -1.13 | -2.56% |
JPMorgan Growth Advantage R6 |